| Title | Journal of NeuroImmune Pharmacology |
| Abbreviation | J. NeuroImmune Pharmacol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Immunology (Q1); Immunology and Allergy (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1) |
| h-index | 91 |
| Overall Rank/Ranking | 2536 |
| SCImago Journal Rank (SJR) | 1.396 |
| Impact Score | 4.59 |
| Publisher | Springer New York |
| Country | United States |
| ISSN | 15571890, 15571904 |
| Best Quartile | Q1 |
| Coverage History | 2006-2023 |
The Journal of Neuroimmune Pharmacology (JNIP) is the peer-reviewed journal of the Society on NeuroImmune Pharmacology. JNIP interfaces the disciplines of immunology, pharmacology and experimental neuroscience by acting as a platform for research discoveries into the pathogenesis and pharmacology of brain disorders affecting the immune system. Original and interdisciplinary scientific contributions, concise "opinion," and broader reviews are welcome. Research areas reporting in JNIP intersect the disciplines of receptor cell signaling, drugs of abuse, neurodegenerative disorders, neurovirology, immunology, and neuropharmacology.
Journal of NeuroImmune Pharmacology is a journal covering the technologies/fields/categories related to Immunology (Q1); Immunology and Allergy (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1). It is published by Springer New York. The overall rank of Journal of NeuroImmune Pharmacology is 2536. According to SCImago Journal Rank (SJR), this journal is ranked 1.396. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 91. The best quartile for this journal is Q1.
The ISSN of Journal of NeuroImmune Pharmacology journal is 15571890, 15571904. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of NeuroImmune Pharmacology is cited by a total of 941 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Journal of NeuroImmune Pharmacology is 4.59, which is computed in 2024 as per its definition. Journal of NeuroImmune Pharmacology IF is decreased by a factor of 1.42 and approximate percentage change is -23.63% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Journal of NeuroImmune Pharmacology is 4.59. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.59 |
| 2022 | 6.01 |
| 2021 | 6.42 |
| 2020 | 3.15 |
| 2019 | 3.75 |
| 2018 | 3.78 |
| 2017 | 3.44 |
| 2016 | 3.38 |
| 2015 | 4.14 |
| 2014 | 4.09 |
Journal of NeuroImmune Pharmacology has an h-index of 91. It means 91 articles of this journal have more than 91 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of NeuroImmune Pharmacology is 15571890, 15571904. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of NeuroImmune Pharmacology is 2536. According to SCImago Journal Rank (SJR), this journal is ranked 1.396. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.396 |
| 2022 | 1.308 |
| 2021 | 1.381 |
| 2020 | 1.219 |
| 2019 | 1.235 |
| 2018 | 1.333 |
| 2017 | 1.379 |
| 2016 | 1.774 |
| 2015 | 1.716 |
| 2014 | 1.587 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2536 |
| 2022 | 2692 |
| 2021 | 2429 |
| 2020 | 3220 |
| 2019 | 3099 |
| 2018 | 2755 |
| 2017 | 2660 |
| 2016 | 1748 |
| 2015 | 1892 |
| 2014 | 2088 |
Journal of NeuroImmune Pharmacology is published by Springer New York. It's publishing house is located in United States. Coverage history of this journal is as following: 2006-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of NeuroImmune Pharmacology is J. NeuroImmune Pharmacol.. This abbreviation ('J. NeuroImmune Pharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Immunology (Q1); Immunology and Allergy (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal of NeuroImmune Pharmacology latest impact IF is 4.59. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 6.42 (2021) and 3.15 (2020), respectively, in the last 10 years. Moreover, its average IS is 4.28 in the previous 10 years.
The Journal of NeuroImmune Pharmacology has an SJR (SCImago Journal Rank) of 1.396, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.774 in 2016 and the lowest being 1.219 in 2020. Furthermore, the average SJR of the Journal of NeuroImmune Pharmacology over the previous 10-year period stands at 4.28.
The latest h-index of the Journal of NeuroImmune Pharmacology is 91.
The Journal of NeuroImmune Pharmacology is published by the Springer New York, with its country of publication being the United States.
The Journal of NeuroImmune Pharmacology is currently ranked 2536 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1748 in 2016 and its lowest position of 3220 in 2020.
The standard ISO4 abbreviation for the Journal of NeuroImmune Pharmacology is J. NeuroImmune Pharmacol..
Journal of NeuroImmune Pharmacology is classified as a journal that the Springer New York publishes.
The Journal of NeuroImmune Pharmacology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal of NeuroImmune Pharmacology is assigned the following International Standard Serial Numbers (ISSN): 15571890, 15571904.
The best quartile for the Journal of NeuroImmune Pharmacology is Q1 (2023).
The Journal of NeuroImmune Pharmacology coverage history can be summarized as follows: 2006-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Historia | journal | 28724 | Universidade Estadual Paulista | 8 | 0.02 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| Materials Research | journal | 15375 | Universidade Federal de Sao Carlos | 71 | 1.46 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 16153 | Taylor and Francis Ltd. | 25 | 1.10 |
| Transnational Corporations | journal | 11181 | UNCTAD United Nations Conference on Trade and Development | 28 | 1.83 |
| Howard Journal of Communications | journal | 10151 | Taylor and Francis Ltd. | 39 | 1.66 |
| Libyan Studies | journal | 19526 | Cambridge University Press | 9 | 0.30 |
| European Surgery - Acta Chirurgica Austriaca | journal | 18870 | Springer Medizin | 24 | 0.60 |
| Asian Textile Journal | trade journal | 27997 | G P S Kwatra | 11 | 0.03 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.59 |
| 2022 | 6.01 |
| 2021 | 6.42 |
| 2020 | 3.15 |
| 2019 | 3.75 |
| 2018 | 3.78 |
| 2017 | 3.44 |
| 2016 | 3.38 |
| 2015 | 4.14 |
| 2014 | 4.09 |
